Yutaka Niihara - Dec 10, 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Stock symbol
EMMA
Transactions as of
Dec 10, 2021
Transactions value $
$14,570
Form type
4
Date filed
12/17/2021, 03:12 PM
Previous filing
Dec 10, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $1.57K +1K +0.01% $1.57* 11.1M Dec 10, 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $2.28K +1.5K +0.01% $1.52* 11.1M Dec 14, 2021 Direct F1, F2
transaction EMMA Common stock, $0.001 par value Purchase $4.56K +3K +0.03% $1.52* 11.1M Dec 15, 2021 Direct F1, F3
transaction EMMA Common stock, $0.001 par value Purchase $6.16K +4K +0.04% $1.54* 11.1M Dec 16, 2021 Direct F1, F4
holding EMMA Common stock, $0.001 par value 92.8K Dec 10, 2021 By Hope International Hospice, Inc. F5
holding EMMA Common stock, $0.001 par value 63K Dec 10, 2021 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.53, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.53, inclusive.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.55, inclusive.
F5 Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.